New methodological approach allows more precise summary of study results

Before new drugs are launched on the market they are tested in clinical studies in which one group of study participants often receives the new treatment and another group receives the current standard treatment. The results of these studies are needed for regulatory approval and later for so-called benefit assessments, which compare the advantages and disadvantages of the new and previous treatment: Is the new treatment more effective, does it have milder or more severe side effects, how do patients do afterwards, and so on. If the new treatment is better overall, it has an “added benefit.”

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
This website uses cookies and asks your personal data to enhance your browsing experience.